- Raffles Medical’s Chinese hospitals are facing a surge in COVID-19 patients due to the relaxation of China’s nationwide restrictions. For its Singapore hospitals, foreign patient levels have recovered close to pre-COVID-19 levels, driven mostly by patients from Indonesia and Southeast Asia.
- - Read this at SGinvestors.io -
No more Zero-COVID for China
- China ended most of its nationwide Zero-COVID policies in a bid to boost its economy and transition into COVID-19 endemicity. After three years of self-isolation and strict lockdowns, China lifted domestic quarantine restrictions as well as relaxed domestic and foreign travel guidelines, whereby inbound travellers are now able to enter the country quarantine-free.
- - Read this at SGinvestors.io -
Mixed bag.
- Read more at SGinvestors.io.
Above is an excerpt from a report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full PDF report @ https://www.utrade.com.sg/.
Llelleythan Tan UOB Kay Hian Research | John Cheong UOB Kay Hian | https://research.uobkayhian.com/ 2023-01-16
Read also UOB's most recent report:
2025-02-25 Raffles Medical - 2024 Results In Line; Share Buyback Announced.
Previous report by UOB:
2024-07-30 Raffles Medical - 1H24 Results Slightly Below Expectations, Margins Remain Soft.
Price targets by 4 other brokers at Raffles Medical Target Prices.
Listing of research reports at Raffles Medical Analyst Reports.
Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividend Payout Dates & Corporate Actions,
Raffles Medical News
